montmorillonit
major
activ
compon
bentonit
multifunct
clay
miner
uniqu
properti
swell
adsorpt
characterist
allow
montmorillonit
wide
use
medic
industri
applic
eisenhour
brown
carretero
pozo
moreov
appli
develop
divers
drug
deliveri
system
overcom
pharmaceut
disadvantag
drug
includ
low
solubl
poor
pharmacokinet
properti
low
bioavail
short
biolog
halflif
mcnerni
et
al
savjani
et
al
griffin
et
al
mould
et
al
consid
characterist
montmorillonit
appli
clay
miner
drug
deliveri
system
could
promis
approach
improv
therapeut
efficaci
drug
bodi
via
sustain
releas
hydrophil
drug
solubil
hydrophob
drug
moreov
montmorillonit
enhanc
function
origin
formul
variou
drug
carrier
review
basic
inform
montmorillonit
includ
physicochem
characterist
introduc
perspect
variou
applic
montmorillonit
pharmaceut
excipi
drug
deliveri
system
discuss
detail
bentonit
natur
clay
contain
clay
miner
smectit
group
form
devitrif
volcan
ash
fell
water
eisenhour
brown
bentonit
name
fort
benton
near
rock
river
wyom
usa
origin
found
wc
knight
clay
excel
swell
adsorpt
colloid
properti
characterist
bentonit
use
mani
industri
applic
includ
foundri
bond
clay
drill
mud
adhes
sealant
bleach
agent
petwast
absorb
desicc
eisenhour
brown
exampl
bentonit
suffici
green
strength
use
bond
agent
sandbas
mold
use
metal
cast
clem
doehler
claydispers
fluid
act
drill
mud
drilllubr
activ
protect
trench
wall
collaps
addit
moistureabsorb
activ
clay
make
use
desicc
raw
bentonit
compos
divers
miner
substanc
quartz
cristobalit
feldspar
zeolit
sever
kind
clay
miner
major
compon
bentonit
montmorillonit
dioctahedr
smectit
swell
adsorpt
properti
bentonit
origin
montmorillonit
pure
montmorillonit
necessari
medic
applic
obtain
purifi
raw
bentonit
montmorillonit
porou
clay
miner
compos
structur
exchang
cation
layer
thick
breadth
nanoclay
sheet
around
nm
respect
mahesh
et
al
layer
consist
two
tetrahedr
silica
sheet
sandwich
octahedr
sheet
alumina
fig
layer
substitut
silica
tetrahedr
sheet
alumina
octahedr
sheet
produc
net
neg
charg
usual
balanc
adsorpt
cation
li
na
layer
rolf
et
al
cation
easili
replac
organ
inorgan
cation
relat
uniqu
hydrophil
swell
adsorpt
fluiditi
properti
montmorillonit
chen
et
al
characterist
montmorillonit
alter
base
cation
adsorb
interlay
sodium
calcium
industri
bentonit
mainli
contain
either
sodium
montmorillonit
calcium
montmorillonit
differ
physic
properti
montmorillonitebas
bentonit
use
differ
field
sodium
montmorillonit
expand
origin
volum
absorb
larg
volum
water
swell
capac
higher
calcium
montmorillonit
addit
sodium
montmorillonit
great
colloid
rheolog
properti
use
mani
industri
applic
includ
drill
mud
sealant
clem
doehler
gleason
et
al
hand
calcium
montmorillonit
less
swell
capabl
sodium
montmorillonit
howev
excel
green
strength
among
miner
binder
use
bond
agent
foundri
mold
sand
clem
doehler
addit
strong
adsorpt
activ
variou
solut
oil
calcium
montmorillonit
also
medic
applic
detoxif
jiang
et
al
one
uniqu
physic
properti
montmorillonit
exhibit
hydrophil
properti
swell
water
surfac
montmorillonit
sheet
neg
charg
autoion
water
easili
infiltr
interlay
song
et
al
hydrophil
contribut
swell
montmorillonit
physic
state
montmorillonit
chang
anhydr
solid
hydrat
materi
semirigid
plastic
gel
suspens
increas
water
content
norrish
low
malfoy
et
al
chang
physic
state
anhydr
solid
gel
call
swell
komin
ogata
sodium
montmorillonit
capabl
increas
volum
time
absorb
water
norrish
swell
occur
ion
hydrat
water
enter
layer
follow
osmot
absorpt
water
swell
pattern
depend
mineralog
size
neg
charg
hydrat
energi
exchang
cation
norrish
baker
et
al
xu
et
al
anoth
characterist
montmorillonit
adsorpt
montmorillonit
layer
contain
exchang
cation
sever
molecul
intercal
interlay
ion
exchang
variou
polar
molecul
short
chain
alcohol
glycerol
carbohydr
ethylen
glycol
ethylen
glycol
monoethyl
ether
aliphat
aromat
amin
organ
dye
adsorb
strongli
surfac
montmorillonit
layer
mikhail
et
al
lagali
et
al
tsai
et
al
hand
nonpolar
molecul
nitrogen
argon
ethan
incorpor
montmorillonit
specif
molecul
adsorb
surfac
infiltr
interlay
limit
interlay
volum
surfac
area
obtain
adsorpt
nonpolar
molecul
less
theoret
valu
lopezgonzalez
deitz
gregg
et
al
vicent
et
al
bentonit
use
intact
form
mani
industri
purpos
howev
bentonit
must
purifi
montmorillonit
use
food
pharmaceut
industri
montmorillonit
swell
rheolog
moistureretain
adsorpt
characterist
wide
studi
activ
ingredi
medicin
first
montmorillonit
adsorpt
properti
remov
toxic
heavi
metal
use
heal
agent
natur
clay
montmorillonit
adsorb
metal
cd
pb
mn
ni
cr
aqueou
solut
bhattacharyya
gupta
addit
metal
montmorillonit
adsorb
unwant
anion
fluorid
water
montmorillonit
incorpor
magnesium
adsorb
fluorid
result
decreas
fluorid
concentr
drink
water
standard
level
thakr
et
al
montmorillonit
also
detoxif
antivir
abil
clay
materi
includ
sodium
montmorillonit
abil
adsorb
bovin
rotavirus
coronavirus
clark
et
al
case
montmorillonit
effect
adsorb
aflatoxin
releas
quantiti
adsorb
desheng
et
al
adsorpt
aflatoxin
onto
montmorillonit
reduc
toxic
effect
shi
et
al
toxic
substanc
nitroaromat
compound
strongli
adsorb
smectit
clay
includ
montmorillonit
haderlein
schwarzenbach
boyd
et
al
li
et
al
robert
et
al
adsorpt
activ
clay
miner
group
montmorillonit
structur
dioctahedr
smectit
develop
commerci
avail
treat
acut
infecti
diarrhea
khediri
et
al
clay
also
use
intestinalh
agent
probioticprotect
agent
one
report
surviv
rate
lactobacillu
casei
immobil
onto
sodium
montmorillonit
increas
gastrointestin
condit
li
et
al
addit
beidellit
montmorillonit
ga
absorpt
coat
featur
discomfortreliev
effect
patient
suffer
constipationpredomin
irrit
bowel
syndrom
cib
et
al
although
symptom
improv
patient
ib
result
indic
montmorillonit
altern
reduc
discomfort
abdomin
pain
patient
cib
montmorillonit
also
use
effect
treat
dermal
problem
contact
dermat
one
studi
show
montmorillonit
effect
quickli
improv
diaper
dermat
topic
agent
calendula
mahmoudi
et
al
addit
bentonit
use
base
cutan
therapi
stabil
zinc
ointment
emulsifi
oil
water
hopkin
variou
drug
adsorb
onto
montmorillonit
interact
surfac
clay
sheet
adsorpt
interact
differ
depend
drug
type
main
mechan
cation
exchang
mcginiti
lach
surfac
montmorillonit
sheet
neg
charg
surfac
charg
balanc
exchang
cation
particular
cation
drug
adsorb
onto
montmorillonit
electrostat
interact
anion
organ
drug
strong
affin
montmorillonit
compar
cation
drug
type
drug
adsorb
weakli
clay
interact
includ
hydrogen
bond
van
der
waal
forc
aguzzi
et
al
sever
factor
determin
adsorpt
extent
drug
onto
montmorillonit
interlay
first
factor
solvent
ph
gener
charg
drug
molecul
depend
ph
solvent
control
adsorpt
desorpt
drug
exampl
adsorpt
vitamin
fluorid
montmorillonit
decreas
ph
increas
karthikeyan
et
al
joshi
et
al
addit
sotalol
hydralazin
show
optimum
ph
adsorpt
degre
adsorpt
decreas
modifi
ph
et
al
et
al
case
decreas
adsorpt
explain
loss
electrostat
interact
competit
h
phdepend
adsorpt
properti
close
associ
releas
drug
montmorillonit
second
factor
temperatur
solut
temperatur
slightli
alter
drug
adsorpt
depend
drug
signific
compar
ph
one
studi
quantiti
vitamin
adsorb
montmorillonit
decreas
gradual
increas
reaction
temperatur
wherea
fluorid
exhibit
opposit
result
karthikeyan
et
al
joshi
et
al
third
factor
ionic
strength
although
applic
drug
sorption
coeffici
kd
tend
decreas
increas
ionic
strength
figueroa
et
al
anoth
factor
affect
degre
adsorpt
initi
drug
concentr
usual
drug
adsorb
onto
montmorillonit
proport
increas
initi
drug
concentr
howev
drug
becom
satur
certain
concentr
quantiti
adsorb
increas
et
al
et
al
joshi
et
al
similar
clay
miner
montmorillonit
cation
exchang
capac
cec
equival
amount
exchang
cation
one
kilogram
addit
adsorpt
interact
drug
degrad
montmorillonit
interlay
exampl
digoxin
intercal
montmorillonit
degrad
rapidli
compar
intact
digoxin
porubcan
et
al
digoxin
molecul
proton
concentr
montmorillonit
interlay
adsorpt
ion
exchang
result
condens
acidcatalyst
effect
increas
rate
degrad
dexamethason
also
degrad
montmorillonit
catalyz
effect
iron
clay
forteza
et
al
coadministr
montmorillonit
drug
often
decreas
oral
bioavail
aguzzi
et
al
macrolid
antibiot
tylosin
oral
administ
montmorillonit
area
curv
decreas
group
receiv
equal
dose
without
montmorillonit
devrees
et
al
addit
format
amphetaminemontmorillonit
complex
reduc
bioavail
amphetamin
human
volunt
mcginiti
lack
aguzzi
et
al
strong
interact
drug
montmorillonit
adsorpt
drug
onto
montmorillonit
result
low
dissolut
low
concentr
drug
gastrointestin
tract
result
intestin
absorpt
rate
decreas
lead
poor
bioavail
prevent
suffici
gastrointestin
absorpt
drug
adsorpt
benefit
decreas
absorpt
toxin
montmorillonit
effect
adsorb
toxin
aflatoxin
nitroaromat
compound
haderlein
schwarzenbach
boyd
et
al
li
et
al
desheng
et
al
robert
et
al
decreas
advers
effect
via
reduc
bioavail
shi
et
al
catalyt
degrad
montmorillonit
also
alter
bioavail
describ
previou
chapter
digoxin
dexamethason
degrad
increas
acidcatalyst
effect
structur
iron
clay
respect
adsorpt
onto
montmorillonit
porubcan
et
al
forteza
et
al
degrad
mechan
reduc
absolut
amount
drug
caus
decreas
gastrointestin
absorpt
adsorpt
onto
montmorillonit
also
chang
pharmacokinet
properti
includ
distribut
drug
organ
exampl
encapsul
glutathion
montmorillonit
increas
oral
bioavail
liver
content
baek
et
al
case
glutathion
montmorillonit
hybrid
protect
glutathion
hydrolysi
intestin
enhanc
oral
bioavail
elev
glutathion
liver
concentr
montmorillonit
also
affect
cellular
uptak
drug
one
studi
cellular
uptak
particl
system
enhanc
incorpor
montmorillonit
dong
feng
studi
report
paclitaxelload
montmorillonitepoli
lacticcoglycol
acid
nanoparticl
increas
drug
uptak
two
human
colon
deriv
cell
line
cell
compar
montmorillonitefre
nanoparticl
claim
incorpor
montmorillonit
formul
strengthen
interact
cell
via
increas
van
der
waal
forc
hydrogen
bond
suggest
drugload
nanoparticl
montmorillonit
may
strongli
interact
mucusepitheli
surfac
gastrointestin
tract
enhanc
cellular
affin
montmorillonit
also
modifi
excret
drug
exampl
montmorilloniteadsorb
amphetamin
decreas
urinari
excret
rate
compar
origin
amphetamin
formul
mcginiti
lack
amphetamin
cation
drug
strongli
intercal
montmorillonit
slow
releas
drug
decreas
absorpt
excret
mani
case
common
effect
montmorillonit
pharmacokinet
relat
decreas
drug
releas
rate
bioavail
caus
adsorpt
drug
onto
montmorillonit
howev
increas
stabl
bioavail
report
drug
explain
glutathion
adsorb
onto
montmorillonit
increas
oral
bioavail
baek
et
al
addit
bioavail
dissolut
rate
poorli
solubl
drug
phenytoin
enhanc
adsorpt
onto
montmorillonit
koleman
et
al
montmorillonit
improv
dissolut
hydrophob
drug
larg
surfac
area
hydrophil
aguzzi
et
al
mani
attempt
made
encapsul
drug
montmorillonit
modifi
releas
pattern
origin
drug
et
al
lin
et
al
joshi
et
al
madurai
et
al
ravishank
et
al
jain
datta
bello
et
al
mix
aqueou
phase
commonli
use
prepar
drugintercal
montmorillonit
complex
aguzzi
et
al
method
usual
use
intercal
hydrophil
drug
montmorillonit
dispers
drug
solut
dissolv
drug
molecul
adsorb
onto
montmorillonit
exchang
cation
interlay
drugmontmorillonit
complex
obtain
collect
dri
solidphas
reach
equilibrium
drugclay
complex
also
attempt
dri
condit
heat
drug
montmorillonit
melt
point
drug
without
aqueou
phase
grind
substanc
homogen
attempt
effect
adsorb
hydrophob
drug
del
hoyo
et
al
aguzzi
et
al
captopriladsorb
montmorillonit
formul
test
evalu
three
differ
intercal
method
dissolv
melt
grind
madurai
et
al
result
dissolut
melt
method
show
similar
properti
howev
formul
prepar
grind
exhibit
significantli
lower
drug
load
sustain
releas
profil
ph
valu
aqueou
phase
import
factor
drug
adsorpt
prepar
drugclay
complex
use
dissolut
method
fig
drug
usual
optimum
ph
valu
adsorpt
extrem
acid
basic
condit
caus
insuffici
drug
intercal
et
al
joshi
et
al
case
cation
drug
problem
depend
pka
valu
drug
molecul
exist
cation
acidicneutr
ph
rang
pka
valu
strongli
adsorb
montmorillonit
interlay
howev
competit
cation
drug
molecul
abund
h
proton
occur
low
ph
result
low
adsorpt
moreov
deproton
drug
molecul
mainli
exist
uncharg
form
basic
ph
rang
pka
valu
result
decreas
intercal
particular
zwitterion
sotalol
anion
basic
condit
disturb
drug
adsorpt
montmorillonit
et
al
howev
higher
drug
encapsul
accomplish
extrem
basic
condit
highest
intercal
percentag
obtain
ph
lin
et
al
specul
open
interlay
basic
condit
contribut
drug
intercal
drugmontmorillonit
complex
show
sustain
vitro
releas
profil
compar
intact
drug
bothiraja
et
al
jain
datta
kaur
datta
exampl
diclofenacload
clay
complex
exhibit
rel
slower
releas
rate
pure
drug
ph
condit
ph
kaur
datta
cation
exchang
clay
interlay
infiltr
drug
molecul
strongli
interact
montmorillonit
layer
electrostat
interact
make
drug
molecul
difficult
desorb
result
sustain
releas
profil
although
releas
rate
watersolubl
drug
usual
decreas
montmorillonit
opposit
effect
observ
hydrophob
drug
explain
previous
montmorillonit
larg
surfac
area
hydrophil
enhanc
drug
wettabl
thu
properti
increas
dissolut
rate
hydrophob
drug
aguzzi
et
al
exampl
phenytoin
poorli
water
solubl
adsorb
montmorillonit
show
increas
drug
dissolut
rate
enhanc
bioavail
koleman
et
al
addit
enhanc
releas
hydrophob
drug
includ
griseofulvin
indomethacin
prednisolon
report
mcginiti
harri
besid
effect
montmorillonit
import
factor
control
drug
releas
rate
ph
releas
medium
mani
case
dissolut
rate
drugclay
complex
increas
higher
ph
joshi
et
al
c
madurai
et
al
kaur
datta
exampl
vitamin
montmorillonit
complex
releas
twice
fast
ph
ph
joshi
et
al
tendenc
explain
chang
charg
interact
similar
adsorpt
tendenc
cation
drug
posit
charg
acid
condit
show
high
affin
neg
charg
montmorillonit
interlay
howev
drug
molecul
lose
charg
deproton
ph
increas
easili
releas
interlay
anion
drug
much
weaker
interact
clay
interlay
compar
cation
drug
mcginiti
lach
although
anion
drug
detach
easili
montmorillonit
solubl
low
acid
condit
slow
releas
kaur
datta
electrostat
repuls
neg
charg
drug
molecul
interlay
surfac
occur
basic
condit
increas
releas
rate
hand
except
exhibit
higher
releas
rate
low
ph
condit
et
al
jain
datta
exampl
faster
venlafaxin
releas
observ
acid
condit
drug
adsorb
montmorillonit
jain
datta
pka
valu
drug
high
enough
posit
charg
larg
ph
rang
competit
proton
influenc
drug
dissolut
similar
drug
intercal
process
adsorb
drug
molecul
exchang
excess
proton
extrem
acid
condit
increas
drug
releas
rate
montmorillonitebas
tablet
prepar
use
dissolutioncontrol
function
ravishank
et
al
solid
dispers
ritonavir
montmorillonit
mixtur
compress
tablet
show
enhanc
dissolut
rate
compar
plain
tablet
explain
montmorillonit
use
drug
carrier
base
adsorpt
properti
howev
clay
limit
use
independ
includ
insuffici
encapsul
organ
molecul
incomplet
drug
releas
clay
defect
overcom
incorpor
polym
polysaccharid
polyest
surfact
moreov
synergist
effect
excipi
observ
prepar
new
composit
contain
montmorillonit
polym
chitosan
polysaccharid
compos
dglucosamin
nacetylglucosamin
obtain
ndeacetyl
chitin
chitosan
biocompat
biodegrad
nontox
studi
carrier
drug
deliveri
system
muzzarelli
et
al
calvo
et
al
depan
et
al
hua
et
al
addit
chitosan
exhibit
posit
charg
interact
neg
charg
mucin
ludwig
show
mucoadhes
properti
contribut
increas
drug
resid
time
schipper
et
al
hou
et
al
chitosan
formul
montmorillonit
prepar
hybrid
composit
lin
et
al
depan
et
al
monvisad
siriphannon
abdeen
salahuddin
bothiraja
et
al
chitosan
posit
charg
adsorb
neg
charg
montmorillonit
interlay
fig
paclitaxel
releas
rate
decreas
coat
drugload
montmorillonit
chitosan
anticanc
activ
improv
bothiraja
et
al
montmorillonit
chitosan
adhes
properti
increas
cell
surfaceadhes
activ
seem
improv
therapeut
effect
ibuprofen
releas
rate
decreas
chitosan
intercal
montmorillonit
compar
origin
chitosan
formul
depan
et
al
sever
attempt
made
prepar
chitosanmontmorillonit
hydrogel
use
high
viscos
chitosan
solut
liu
et
al
hua
et
al
cojocariu
et
al
b
mani
case
increas
montmorillonit
content
decreas
drug
releas
rate
addit
incorpor
montmorillonit
decreas
swellabl
formul
cojocariu
et
al
abdeen
salahuddin
ofloxacinload
chitosan
hydrogel
show
fast
drug
releas
low
ph
condit
montmorillonit
decreas
releas
rate
hua
et
al
consid
result
intercal
montmorillonit
may
prevent
disintegr
chitosan
low
ph
result
sustain
releas
besid
direct
effect
montmorillonit
control
releas
profil
also
use
improv
electrosensit
perform
hydrogel
releas
rate
electrosensit
hydrogel
revers
increas
electr
field
respons
decreas
gradual
repeat
electr
stimul
liu
et
al
howev
incorpor
montmorillonit
chitosan
hydrogel
contribut
maintain
regular
respons
revers
moreov
montmorillonitechitosan
composit
use
fabric
particul
formul
nanoparticl
microspher
bead
wang
et
al
hua
et
al
yan
et
al
hou
et
al
similar
formul
montmorillonit
usual
increas
drug
encapsul
sustain
drug
releas
gener
releas
rate
drugclay
complex
increas
high
ph
tendenc
chang
physicochem
properti
chitosan
unlik
montmorillonit
chitosan
posit
charg
chitosanbas
formul
disintegr
low
ph
condit
increas
drug
releas
hua
et
al
b
ofloxacinload
chitosanmontmorillonit
microspher
show
biphas
releas
pattern
ph
character
rapid
releas
chitosan
matrix
sustain
releas
montmorillonit
interlay
hua
et
al
algin
obtain
brown
alga
bacteria
polysaccharid
compos
acid
acid
yang
et
al
pongjanyakul
suksri
similar
chitosan
algin
biodegrad
mucoadhes
drug
releasemodifi
activ
use
control
drug
deliveri
system
elkamel
et
al
karlsen
shi
et
al
howev
contrast
chitosan
algin
carboxyl
group
neg
charg
dissolv
algin
form
hydrogel
crosslink
carboxyl
group
dival
cation
includ
chen
et
al
nho
et
al
algin
use
fabric
drugload
gelbas
bead
use
gelat
mechan
gener
algin
bead
show
faster
drug
releas
higher
ph
algin
use
prepar
phsensit
drug
carrier
howev
hydrophil
matrix
suffici
encapsul
watersolubl
drug
drug
quickli
releas
algin
phase
crosslink
step
iliescu
et
al
moreov
bead
disintegr
easili
high
ph
environ
caus
rapid
drug
releas
use
sustain
releas
system
overcom
drawback
alginatemontmorillonitebas
hydrogel
formul
propos
oh
et
al
kevadiya
et
al
b
iliescu
et
al
jeong
jung
liu
et
al
yan
et
al
iliescu
et
al
unlik
chitosan
algin
intercal
montmorillonit
interlay
howev
edg
montmorillonit
layer
posit
charg
interact
algin
electrostat
enhanc
rigid
algin
matrix
fig
kevadiya
et
al
b
iliescu
et
al
similar
chitosanmontmorillonit
composit
montmorillonit
enhanc
drug
encapsul
decreas
drug
releas
rate
algin
matrix
adsorpt
properti
oh
et
al
kevadiya
et
al
jeong
jung
yan
et
al
even
incorpor
montmorillonit
alginatebas
formul
show
rapid
drug
releas
neutral
condit
acid
condit
oh
et
al
jeong
jung
liu
et
al
proton
carboxyl
group
algin
maintain
intermolecular
hydrogen
bond
low
ph
jeong
jung
howev
neg
charg
carboxyl
group
lose
hydrogen
bond
neutral
ph
affect
intermolecular
repuls
forc
mahkam
et
al
phenomenon
induc
swell
disintegr
algin
formul
caus
rapid
drug
releas
montmorillonit
also
appli
alginatebas
film
pongjanyakul
suksri
alboofetileh
et
al
prasetia
et
al
clay
chang
properti
film
exampl
montmorillonit
increas
tear
resist
tensil
strength
decreas
percent
elong
prasetia
et
al
addit
dissolut
rate
film
drug
also
decreas
incorpor
montmorillonit
pongjanyakul
suksri
prasetia
et
al
synthes
natur
polym
also
use
develop
drug
deliveri
system
exampl
poli
acryl
acid
fabric
polymer
acryl
acid
studi
hydrogel
formul
water
absorpt
mucoadhes
properti
nho
et
al
calixto
et
al
addit
sever
method
includ
crosslink
hydrogen
bond
format
polym
attempt
modifi
origin
properti
poli
acryl
acid
includ
mechan
strength
swell
effect
katono
et
al
elliott
et
al
montmorillonit
appli
acryl
acid
deriv
design
newli
structur
drug
carrier
system
lee
chen
thatiparti
et
al
bhattacharya
et
al
hosseinzadeh
et
al
one
interest
approach
polymer
acryl
acid
monom
montmorillonit
suspens
rather
mix
poli
acryl
acid
montmorillonit
fig
lee
chen
report
gel
strength
prepar
hydrogel
increas
releas
cation
drug
decreas
moreov
similar
algin
film
incorpor
montmorillonit
increas
tensil
strength
decreas
degrad
drug
releas
rate
polyest
polyol
acrylatebas
film
thatiparti
et
al
polyamid
polyacrylamid
also
studi
montmorillonitemix
formul
kevadiya
et
al
salahuddin
et
al
montmorillonit
sometim
modifi
cation
molecul
prior
polymer
prepar
polymermontmorillonit
composit
explain
exampl
trimethylammonium
chlorid
intercal
montmorillonit
interlay
lee
chen
modifi
montmorillonit
well
exfoli
effici
crosslink
acryl
monom
exfoli
contribut
increas
montmorillonit
surfac
area
enhanc
interact
gel
matrix
anoth
studi
dodecylamin
intercal
increas
hydrophob
montmorillonit
interlay
thatiparti
et
al
hydrophob
monom
infiltr
well
organomodifi
clay
result
wellmix
composit
tabl
polyest
includ
polyglycol
acid
polylact
acid
polycaprolacton
poli
lacticcoglycol
acid
biodegrad
biocompat
thermoplast
polym
prepar
ringopen
polymer
cyclic
diester
athanasi
et
al
dinarvand
et
al
hydrolyt
degrad
nontox
polyest
use
variou
biomed
applic
gentil
et
al
polym
hydrophob
usual
use
control
deliveri
waterinsolubl
drug
dinarvand
et
al
mani
studi
introduc
montmorillonit
polyesterbas
formul
control
drug
releas
origin
formul
feng
et
al
campbel
et
al
jain
datta
report
incorpor
montmorillonit
alway
delay
drug
releas
moreov
montmorillonit
enhanc
cellular
uptak
cytotox
docetaxelload
polylact
acidbas
nanoparticl
indic
clay
interact
cell
hydrogen
bond
van
der
waal
forc
lavi
stotzki
feng
et
al
montmorillonit
formul
variou
pharmaceut
excipi
includ
solubil
polysaccharid
intercal
organ
molecul
increas
montmorillonit
ad
polysaccharid
formul
ie
guar
gum
mansa
detelli
soy
flour
starch
use
montmorillonit
prepar
biodegrad
nanoparticl
sustain
releas
profil
banik
et
al
namazi
belali
poloxam
ad
solubil
modifi
montmorillonit
interlay
datta
kaur
interestingli
releas
rate
diclofenac
montmorillonit
decreas
incorpor
poloxam
specul
major
drug
success
intercal
montmorillonit
ad
poloxam
result
sustain
drug
releas
moreov
attempt
adsorb
anion
instead
cation
drug
montmorillonit
made
anion
drug
success
load
interlay
intercal
cation
monom
interlay
clay
prior
adsorpt
drug
molecul
fig
mahkam
et
al
studi
intercal
anion
drug
ie
naproxen
show
increas
releas
rate
high
ph
condit
electrostat
repuls
forc
deproton
group
furthermor
incorpor
montmorillonit
methylcellulosepectinbas
film
effect
montmorillonitefre
film
transderm
drug
deliveri
applic
saha
et
al
montmorillonit
clay
miner
bentonit
use
variou
pharmaceut
applic
clay
exhibit
repres
characterist
swell
adsorpt
properti
contribut
improv
andor
modifi
drug
deliveri
system
montmorillonit
form
composit
variou
polym
chitosan
algin
polyacryl
acid
therebi
modifi
characterist
polym
releas
pattern
mechan
properti
moreov
surfac
modif
montmorillonit
sheet
attempt
encapsul
noncation
drug
prepar
composit
formul
polym
gener
montmorillonit
sustain
drug
releas
mani
formul
strongli
adsorb
drug
molecul
howev
montmorillonit
also
enhanc
dissolut
rate
bioavail
hydrophob
drug
cation
exchang
activ
adsorpt
releas
pattern
drug
montmorilloniteincorpor
formul
mainli
affect
ph
thu
montmorillonit
promis
materi
use
pharmaceut
excipi
divers
drug
deliveri
system
